X0306 4 2022-12-16 0 0001744659 Akero Therapeutics, Inc. AKRO 0001778739 White William Richard C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 21.10 2022-12-16 4 A 0 29073 0.00 A 2031-12-07 Common Stock 29073 87221 D On December 8, 2021, the Reporting Person was granted an option to purchase 87,221 shares of the Issuer's Common Stock, subject to the achievement of three specified performance milestones. On December 16, 2022, the third performance milestone was achieved, resulting in the vesting of 29,073 shares underlying such option. /s/ Jonathan Young, Attorney-in-Fact 2022-12-20